Cash flow Statement (Quarterly, GAAP
in millions $) |
(Sep 30 2023) 9 Months |
(Jun 30 2023) 6 Months |
(Mar 31 2023) 3 Months |
(Dec 31 2022) 12 Months |
(Sep 30 2022) 9 Months |
Income |
-242.96 |
-130.81 |
-53.07 |
-650.18 |
-539.60 |
Depreciation & amortization |
14.94 |
10.01 |
5.05 |
24.17 |
18.33 |
Amortization of Other Assets |
- |
- |
- |
- |
- |
Increase (Decrease) in Deferred Revenue
|
- |
- |
- |
- |
- |
Restructuring & Impairment Charges |
- |
- |
- |
- |
- |
Provision for Loan, Lease, and Other Losses |
- |
- |
- |
- |
- |
Inventories Decrease /-Increase |
- |
- |
- |
- |
- |
R & D, Environmental and Other Expense |
- |
- |
- |
- |
- |
Gain (Loss) on Disposition of Assets |
- |
- |
- |
- |
- |
Share-based Compensation |
62.61 |
42.64 |
20.88 |
97.95 |
75.14 |
Income (Loss) from Equity Method Investments |
- |
- |
- |
- |
- |
Foreign Currency Transaction Gain (Loss), Unrealized |
- |
- |
- |
- |
- |
Income Loss From Equity Method Investments And Investment Compensation Expense |
- |
- |
- |
- |
- |
Increase Decrease In Contract With Customer Liability |
7.00 |
- |
- |
-0.76 |
-1.01 |
Non Cash Expense Related To Collaboration Agreement |
- |
- |
- |
- |
- |
Acquired In Process Research And Development |
2.50 |
1.50 |
- |
- |
- |
Income taxes |
- |
- |
- |
- |
- |
Losses/ -gains on Investments net |
- |
- |
- |
- |
- |
Increase (Decrease) in Accounts Receivable |
- |
-70.00 |
- |
0.31 |
0.26 |
Increase (Decrease) in Accounts Payable and Accrued Liabilities |
-11.06 |
13.64 |
25.21 |
5.16 |
36.26 |
Accrued Expense |
- |
- |
- |
- |
- |
Deferred Revenue and Customer Advances and Deposits |
- |
- |
- |
- |
- |
Increase (Decrease) in Prepaid Expense and Other Assets |
16.77 |
15.95 |
12.04 |
1.60 |
7.06 |
Other Working Capital |
-0.60 |
-0.49 |
-0.17 |
-1.52 |
-2.18 |
Other Noncash Income (Expense) |
-11.78 |
-5.62 |
-0.97 |
12.47 |
12.25 |
Other net |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Operating Activities |
-1.73 |
-1.28 |
-0.18 |
15.31 |
10.83 |
Discontinued operations |
- |
- |
- |
- |
- |
Net Cash flow from
Operating Activities |
-164.30 |
-124.45 |
8.80 |
-495.74 |
-382.41 |
Capital Expenditures |
-8.73 |
-6.61 |
-3.06 |
-37.19 |
-31.00 |
Sale of Capital Items |
- |
- |
- |
- |
- |
Proceeds from Sale and Maturity of Marketable Securities |
1,165.09 |
795.23 |
386.52 |
1,196.33 |
871.28 |
Payments to Acquire Marketable Securities |
-697.76 |
-452.36 |
-265.63 |
-1,417.80 |
-923.40 |
Real Estate Investments |
- |
- |
- |
- |
- |
Proceeds From Contribution Of Intellectual Property To Equity Method Investee |
- |
- |
- |
- |
- |
Net Cash And Restricted Cash Received In Connection With Acquisition Of Controlling Interest |
- |
- |
- |
- |
- |
Increase (Decrease) in Restricted Cash |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Loans |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Deposits |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Investments |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank |
- |
- |
- |
- |
- |
Payments to Acquire in Process Research and Development |
-2.50 |
-1.50 |
- |
- |
- |
Payments to Acquire Equity Method Investments |
- |
- |
- |
- |
- |
Sale of businesses |
- |
- |
- |
- |
- |
Accounts payable |
- |
- |
- |
- |
- |
Receivables |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Investing Activities |
- |
- |
- |
- |
- |
Other Net |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
Discontinued operations |
- |
- |
- |
- |
- |
Net Cash flow from
Investing Activities |
456.10 |
334.75 |
117.83 |
-258.66 |
-83.12 |
Short-term debt Net |
- |
- |
- |
- |
- |
Other borrowing transactions |
- |
- |
- |
- |
- |
Long-term debt - borrowings |
- |
- |
- |
- |
- |
Long-term debt - repayments |
- |
- |
- |
- |
- |
Federal Home Loan Bank and Federal Funds |
- |
- |
- |
- |
- |
Issuances/ -repurchases
of Comm. Stock |
23.73 |
22.17 |
5.40 |
38.59 |
36.11 |
Partnership and Parent Transactions |
- |
- |
- |
- |
- |
Issuances/ -repurchases
of Pref. Stock |
- |
- |
- |
- |
- |
Deposits, Annuities, Contract Holders Funds |
- |
- |
- |
- |
- |
Other financing activities net |
- |
- |
- |
- |
- |
Other net |
-0.75 |
-1.03 |
-2.66 |
-2.12 |
-4.92 |
Proceeds From Issuance Of Restricted Shares |
- |
- |
- |
- |
- |
Capital Expenditures Incurred But Not Yet Paid |
0.75 |
1.03 |
2.66 |
4.92 |
5.02 |
Debt Conversion Converted Instrument Amount |
- |
- |
- |
- |
- |
Noncash Contribution Of Intellectual Property To Equity Method Investee |
- |
- |
- |
- |
- |
Issuance Costs For Initial Public Offering In Accounts Payable And Accrued Expenses |
- |
- |
- |
- |
- |
Payments of Dividends, Preferred Stock and Preference Stock |
- |
- |
- |
- |
- |
Dividends paid |
- |
- |
- |
- |
- |
Net Cash flow from
Financing Activities |
23.73 |
22.17 |
5.40 |
38.59 |
36.11 |
Effect of exchange rate on cash flow |
0.01 |
0.06 |
0.03 |
-0.08 |
-0.20 |
Discontinued operations |
- |
- |
- |
- |
- |
Free
Cash Flow |
-173.03 |
-131.06 |
5.74 |
-532.93 |
-413.41 |
Total Cash Flow |
315.54 |
232.54 |
132.06 |
-715.88 |
-429.62 |
Cash & cash equiv. at beg.
of the Year |
- |
- |
- |
- |
- |
Cash & cash equivalents at
end of period |
- |
- |
- |
- |
- |
Cash Interests paid |
- |
- |
- |
- |
- |
Cash Income taxes paid |
- |
- |
- |
- |
- |